Effect of Helicobacter Pylori Eradication on Platelet Recovery in Patients with Chronic Idiopathic Thrombocytopenic Purpura
Overview
Authors
Affiliations
Background: A relationship between Helicobacter pylori infection and idiopathic thrombocytopenic purpura (ITP) has previously been reported. We determined the prevalence of H pylori infection in Japanese patients with chronic ITP and the effect of its eradication on platelet count.
Methods: The study population comprised 53 Japanese adults with chronic ITP and a platelet count of less than 100 x 10(3)/ micro L. A (13)C-urea breath test was performed to determine H pylori infection status. Those patients who were H pylori positive gave written informed consent and received eradication therapy. The effect of H pylori eradication on platelet count was evaluated up to 6 months after therapy. Clinical parameters were compared between responders to the therapy (increase in platelet count) and nonresponders, as well as between H pylori-positive and -negative patients.
Results: Of the 53 patients with chronic ITP in the study, 39 (74%) were H pylori positive. Of the 32 infected patients who received treatment, H pylori was successfully eradicated in 27 patients (84%). In 10 (37%) of these patients, this resulted in a favorable platelet response. A partial response was seen in 5 additional patients (19%). A significant (P<.001) increase in platelet count was demonstrated in patients in whom H pylori was successfully eradicated but not in patients who were unsuccessfully treated or in untreated patients. Current corticosteroid therapy was reported more often in nonresponders than in responders.
Conclusion: Eradication of H pylori may prove effective in increasing platelet count in H pylori-positive patients with chronic ITP.
Helicobacter pylori-Associated Immune Thrombocytopenia: Diagnostic and Therapeutic Approach.
Gosavi S, Krishnan G, Kumar V, Nityandila C, Rao A, Singh S Ann Afr Med. 2024; 23(3):248-254.
PMID: 39034543 PMC: 11364310. DOI: 10.4103/aam.aam_170_23.
Han B, Kim H, Yhim H, Oh D, Bae S, Shin H Ann Hematol. 2022; 101(7):1435-1445.
PMID: 35643952 DOI: 10.1007/s00277-022-04782-2.
Ihtesham A, Maqbool S, Nadeem M, Bilawal Abbas Janjua M, Sundus O, Bakht Naqqash A AIMS Microbiol. 2021; 7(3):284-303.
PMID: 34708173 PMC: 8500795. DOI: 10.3934/microbiol.2021018.
Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion.
Belizaire R, Makar R Transfus Med Rev. 2020; 34(4):242-249.
PMID: 33129606 PMC: 7494440. DOI: 10.1016/j.tmrv.2020.09.002.
Role of Eradication Therapy on Platelet Recovery in Chronic Immune Thrombocytopenic Purpura.
Sheema K, Ikramdin U, Arshi N, Farah N, Imran S Gastroenterol Res Pract. 2017; 2017:9529752.
PMID: 28194178 PMC: 5282406. DOI: 10.1155/2017/9529752.